A Study of U-500 Insulin (LY041001) in Participants With Type 2 Diabetes
NCT02588950
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
11
Enrollment
INDUSTRY
Sponsor class
Stopped
Slow enrollment
Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG:
U-500R
Sponsor
Eli Lilly and Company